Cargando…
Diabetic macular edema: Evidence-based management
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes mellitus. Its pathophysiology starts with decreased retinal oxygen tension that manifests as retinal capillary hyper...
Autores principales: | Browning, David J, Stewart, Michael W, Lee, Chong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256891/ https://www.ncbi.nlm.nih.gov/pubmed/30451174 http://dx.doi.org/10.4103/ijo.IJO_1240_18 |
Ejemplares similares
-
Vitrectomy for center-involved diabetic macular edema
por: Browning, David J, et al.
Publicado: (2016) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart, Michael W
Publicado: (2015) -
Update on corticosteroids for diabetic macular edema
por: Schwartz, Stephen G, et al.
Publicado: (2016) -
Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart, Michael W
Publicado: (2013) -
Updates in the Management of Diabetic Macular Edema
por: Mathew, Christopher, et al.
Publicado: (2015)